Sport Integrity Australia acknowledges the decision of the International Tennis Integrity Agency (ITIA) to impose a ten-month period of Ineligibility on Australian athlete Thomas Fancutt for the breach of Article 2.2 of the World Anti-Doping Code (The Code).
Mr Fancutt, a tennis player admitted to receiving an intravenous infusion over the accepted limit of 100ml in a 12-hour period (Prohibited Method) on 3 December 2024.
Mr Fancutt entered into a voluntary provisional suspension on 19 March 2025 in acceptance of the alleged Anti-Doping Rule Violation.
Mr Fancutt is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy between 19 March 2025 – 18 January 2026. He is also not permitted to compete in a non-Signatory professional league or Event organised by a non-Signatory International Event organisation or a non-Signatory national-level event organisation.
|
Our latest news, resources, podcasts, courses and webinars:
|
Additional information on the Prohibited Method
Classified by the World Anti-Doping Agency (WADA) as a Prohibited Method, intravenous infusions of more than 100mls per 12-hour period are classified as a violation of the anti-doping rules.
Athletes who require an infusion during the course of a hospital treatment, surgical procedure, or clinical diagnostic investigation are permitted where the athlete has been granted a Therapeutic Use Exemption either before or after treatment.
Intravenous injection or infusion occurs when a substance is given directly into the vein through a needle. It could be delivered in a small volume with a simple syringe, or in a large volume through a specialized needle, tubing, and an IV bag.